Revolution Medicines Inc (RVMD)
US$ 38.770.49%
Price Chart
Key Statistics
Market Cap
$ 7.39B
P/E Ratio
0.00
Revenue (TTM)
$ 742K
Volume
1.07M
52W High
$ 62.40
52W Low
$ 29.17
Dividend Yield
0.00%
Beta
1.10
Technicals
50-Day MA
39.1443
200-Day MA
43.4342
52 Week High
62.4
52 Week Low
29.17
About RVMD
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
Employees
616
Headquarters
Redwood City, CA
CEO
Dr. Mark A. Goldsmith Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg